These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9112945)

  • 1. The role of computed tomography in the management of ovarian tumours of borderline malignancy.
    Dobson M; Carrington BM; Radford JA; Buckley CH; Crowther D
    Clin Radiol; 1997 Apr; 52(4):280-3. PubMed ID: 9112945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller.
    Chi DS; Barlin JN; Ramirez PT; Levenback CF; Mironov S; Sarasohn DM; Iyer RB; Dao F; Hricak H; Barakat RR
    Int J Gynecol Cancer; 2010 Apr; 20(3):353-7. PubMed ID: 20375796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography, diagnosis, staging and follow-up of pure granulosa cell tumour of the ovary.
    MacSweeney JE; King DM
    Clin Radiol; 1994 Apr; 49(4):241-5. PubMed ID: 8162679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominopelvic CT scan findings after surgery for ovarian cancer.
    Razzaq R; Carrington BM; Hulse PA; Kitchener HC
    Clin Radiol; 1998 Nov; 53(11):820-4. PubMed ID: 9833785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.
    Nam EJ; Yun MJ; Oh YT; Kim JW; Kim JH; Kim S; Jung YW; Kim SW; Kim YT
    Gynecol Oncol; 2010 Mar; 116(3):389-94. PubMed ID: 19926121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
    De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
    Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Borderline ovarian tumors: clinical analysis of 114 cases].
    Makarewicz H; Olszewski J; Konefka T; Milczek T; Emerich J
    Ginekol Pol; 1999 Mar; 70(3):147-51. PubMed ID: 10390917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is postoperative computed tomography evaluation a prognostic indicator in patients with optimally debulked advanced ovarian cancer?
    Lorusso D; Sarno I; Di Donato V; Palazzo A; Torrisi E; Pala L; Marchiano A; Raspagliesi F
    Oncology; 2014; 87(5):293-9. PubMed ID: 25139548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer.
    Risum S; Loft A; Høgdall C; Berthelsen AK; Høgdall E; Lundvall L; Nedergaard L; Engelholm SA
    Acta Oncol; 2011 Apr; 50(3):415-9. PubMed ID: 20698810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
    Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N;
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
    Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
    Gynecol Oncol; 2010 Mar; 116(3):395-8. PubMed ID: 20042226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CT in the evaluation of ovarian malignancy.
    Amendola MA
    Crit Rev Diagn Imaging; 1985; 24(4):329-68. PubMed ID: 3896652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics].
    Kindermann G; Maassen V; Kuhn W
    Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):687-94. PubMed ID: 8582588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours.
    Querleu D; Papageorgiou T; Lambaudie E; Sonoda Y; Narducci F; LeBlanc E
    BJOG; 2003 Feb; 110(2):201-4. PubMed ID: 12618166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.
    Michielsen K; Dresen R; Vanslembrouck R; De Keyzer F; Amant F; Mussen E; Leunen K; Berteloot P; Moerman P; Vergote I; Vandecaveye V
    Eur J Cancer; 2017 Sep; 83():88-98. PubMed ID: 28734146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of borderline ovarian tumours.
    Gershenson DM
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():49-59. PubMed ID: 27780698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
    Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
    Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET/CT as a molecular biomarker in ovarian cancer.
    Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
    Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.